Save time and get answers to complex questions with AI chat
When genetic tenofovir alafenamide be available in us?When will generic fiasap insulin be available?What is dabrafenib mesylate msn patent issue?Does lipitor's use influence blood pressure medication type?The expiration date of the key patent for guselkumab?
See the DrugPatentWatch profile for Lactulose
Lactulose Solution, USP refers to the USP-grade lactulose syrup used as an osmotic laxative and in hepatic encephalopathy. It is a non-digestible disaccharide (galactose–fructose). Key points: - Common strength: 3.35 g lactulose per 5 mL (equivalently 10 g per 15 mL). Many products are labeled as 10 g/15 mL. - Appearance: Clear to slightly yellow, sweet-tasting syrup. - Uses: - Constipation relief (osmotic laxative) - Management of hepatic encephalopathy by lowering colonic pH and reducing ammonia absorption - Typical dosing (adult, though always follow clinician’s instructions): - Constipation: usually 15–30 mL per day, may titrate up to 45–60 mL/day to achieve soft stools - Hepatic encephalopathy: often 20–40 mL per day in divided doses, adjusted to obtain 2–3 soft stools per day - Administration: Oral; can be taken alone or mixed with water/juice. - Common adverse effects: Flatulence, abdominal cramping, diarrhea; possible electrolyte shifts with long-term use. - Contraindications: Galactosemia; caution in diabetes due to sugar content; use under medical supervision for hepatic encephalopathy. - Storage: Room temperature, protect from extreme heat and moisture. - USP specifics: The lactulose solution marketed as “Lactulose Solution, USP” conforms to the USP monograph, which covers identity, assay (lactulose content), impurities/related substances, pH, loss on drying, microbial limits, packaging, etc. For exact limits, refer to the USP–NF text or the product’s label. If you’re asking for a precise monograph excerpt or limits, tell me and I can summarize the key USP-NF requirements or point you to where to find them.
Other Questions About Lactulose :